Literature DB >> 21528182

Microcirculation and metastasis in a new mouse mammary tumor model system.

A Cheung1, L Young, P Chen, C Chao, A Ndoye, P Barry, W Muller, R Cardiff.   

Abstract

Two new metastatic mouse mammary tumor transplant lines have been established in nude mice. The Met-1 line, with the polyoma virus middle T (PyV-MT) transgene, metastasized with 100% efficiency. The Db-7 line, expressing a PyV-MT transgene mutated at positions 315 and 322, metastasized with 8.8% efficiency. Histology and computer-assisted intravital microscopy demonstrated that internal microcirculation in Met-1 was more complex than Db-7; Met-1 exhibited higher microvessel density and tortuosity (P < 0.0001). These indices of microvascular complexity correlated with the higher Met-1 metastatic rate (P < 0.0001). These two transplantable lines will be useful for investigating the complex relationship between angiogenesis and metastasis.

Entities:  

Year:  1997        PMID: 21528182

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  15 in total

Review 1.  Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.

Authors:  Michele M Fluck; Brian S Schaffhausen
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

2.  Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation.

Authors:  Benjamin B Davis; David A Thompson; Laura L Howard; Christophe Morisseau; Bruce D Hammock; Robert H Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-12       Impact factor: 11.205

3.  Syngeneic mouse mammary carcinoma cell lines: two closely related cell lines with divergent metastatic behavior.

Authors:  Alexander D Borowsky; Ruria Namba; Lawrence J T Young; Kent W Hunter; J Graeme Hodgson; Clifford G Tepper; Erik T McGoldrick; William J Muller; Robert D Cardiff; Jeffrey P Gregg
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

Review 4.  CD44-mediated oncogenic signaling and cytoskeleton activation during mammary tumor progression.

Authors:  L Y Bourguignon
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-07       Impact factor: 2.673

5.  In vivo blood flow abnormalities in the transgenic knockout sickle cell mouse.

Authors:  S H Embury; N Mohandas; C Paszty; P Cooper; A T Cheung
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

6.  Requirement for both Shc and phosphatidylinositol 3' kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis.

Authors:  M A Webster; J N Hutchinson; M J Rauh; S K Muthuswamy; M Anton; C G Tortorice; R D Cardiff; F L Graham; J A Hassell; W J Muller
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

7.  An integrin binding-defective mutant of insulin-like growth factor-1 (R36E/R37E IGF1) acts as a dominant-negative antagonist of the IGF1 receptor (IGF1R) and suppresses tumorigenesis but still binds to IGF1R.

Authors:  Masaaki Fujita; Katsuaki Ieguchi; Dora M Cedano-Prieto; Andrew Fong; Charles Wilkerson; Jane Q Chen; Mac Wu; Su-Hao Lo; Anthony T W Cheung; Machelle D Wilson; Robert D Cardiff; Alexander D Borowsky; Yoko K Takada; Yoshikazu Takada
Journal:  J Biol Chem       Date:  2013-05-21       Impact factor: 5.157

8.  Ets2-dependent stromal regulation of mouse mammary tumors.

Authors:  Albert K Man; Lawrence J T Young; John A Tynan; Jacqueline Lesperance; Mikala Egeblad; Zena Werb; Craig A Hauser; William J Muller; Robert D Cardiff; Robert G Oshima
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

9.  Control of mammary tumor differentiation by SKI-606 (bosutinib).

Authors:  L Hebbard; G Cecena; J Golas; J Sawada; L G Ellies; A Charbono; R Williams; R E Jimenez; M Wankell; K T Arndt; S Q DeJoy; R A Rollins; V Diesl; M Follettie; L Chen; E Rosfjord; R D Cardiff; M Komatsu; F Boschelli; R G Oshima
Journal:  Oncogene       Date:  2010-09-06       Impact factor: 9.867

Review 10.  Tyrosine kinase signalling in breast cancer: tyrosine kinase-mediated signal transduction in transgenic mouse models of human breast cancer.

Authors:  E R Andrechek; W J Muller
Journal:  Breast Cancer Res       Date:  2000-04-12       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.